Pre-Assessment V2 Exam Actual Exam
2026/2027 with Detailed Rationales |
Complete Exam-Style Questions | Pass
Guaranteed – A+ Graded
SECTION 1: Neurotransmitters, Receptors, & Basic
Pharmacology (Questions 1–25)
Q1: A nursing student is reviewing neurotransmitter functions. Which neurotransmitter is primarily
responsible for regulating mood, sleep, appetite, and pain perception?
A. Dopamine, which mainly controls voluntary movement and reward pathways
B. Serotonin, which modulates mood, sleep cycles, appetite, and nociception [CORRECT]
C. GABA, which serves as the primary excitatory neurotransmitter in the brain
D. Glutamate, which is mainly involved in inhibitory signaling and sedation
,Correct Answer: B
Rationale: The best answer is serotonin. This neurotransmitter plays a central role in mood
regulation, sleep architecture, appetite control, and pain modulation. Remember that in clinical
practice, when we see medications affecting these domains—like SSRIs improving mood and
sleep—we're targeting serotonergic pathways. Dopamine is more involved in movement and
reward, GABA is inhibitory (not excitatory), and glutamate is actually the main excitatory
neurotransmitter, not inhibitory.
Q2: A patient asks why their antidepressant takes several weeks to work. The nurse explains that
this delay is primarily due to:
A. The time required for the liver to fully metabolize the drug and reach steady state
B. Adaptive changes in receptor sensitivity and downstream neuronal signaling pathways
[CORRECT]
C. The need for the medication to first deplete existing neurotransmitter stores
D. A required build-up period before the blood-brain barrier permits drug entry
Correct Answer: B
Rationale: The best answer is adaptive changes in receptor sensitivity. This is correct because
while antidepressants quickly increase synaptic monoamine levels, the therapeutic effect depends
on slower adaptive processes—like desensitization of presynaptic autoreceptors and changes in
postsynaptic signaling cascades. This aligns with the mechanism that explains why patients need
2-4 weeks before mood improvement occurs, even though pharmacokinetic steady state happens
sooner.
,Q3: Which receptor type, when blocked by antipsychotic medications, is primarily responsible for
reducing positive symptoms of schizophrenia?
A. Serotonin 5-HT2A receptors, which mainly modulate appetite and sleep
B. Dopamine D2 receptors, which are overactive in mesolimbic pathways in psychosis [CORRECT]
C. Norepinephrine alpha-1 receptors, which primarily affect blood pressure
D. Acetylcholine muscarinic receptors, which mainly influence memory
Correct Answer: B
Rationale: The best answer is dopamine D2 receptors. This aligns with the dopamine hypothesis of
schizophrenia, where hyperactivity in the mesolimbic pathway produces positive symptoms like
hallucinations and delusions. First-generation antipsychotics work primarily through D2
antagonism, and even atypical agents need some D2 affinity for efficacy. The other receptors listed
play roles in side effect profiles rather than core antipsychotic action.
Q4: A nurse is teaching about GABA's role in anxiety disorders. The correct explanation includes
that GABA is:
A. The brain's major excitatory neurotransmitter that increases neuronal firing rates
B. An inhibitory neurotransmitter that reduces neuronal excitability and produces calming effects
[CORRECT]
, C. A hormone produced by the adrenal gland during stress responses
D. A precursor molecule converted into dopamine in the limbic system
Correct Answer: B
Rationale: The best answer is that GABA is an inhibitory neurotransmitter. This is correct because
GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the CNS, binding to
GABA-A receptors to allow chloride influx and hyperpolarize neurons. This explains why
benzodiazepines, which enhance GABA-A receptor function, produce anxiolytic and sedative
effects. Remember that in clinical practice, enhancing GABAergic tone helps calm the excessive
neuronal activity seen in anxiety states.
Q5: The nurse is reviewing a medication's mechanism and notes it blocks the reuptake of both
serotonin and norepinephrine. This describes which drug class?
A. Selective serotonin reuptake inhibitors (SSRIs)
B. Serotonin-norepinephrine reuptake inhibitors (SNRIs) [CORRECT]
C. Tricyclic antidepressants (TCAs)
D. Monoamine oxidase inhibitors (MAOIs)
Correct Answer: B
Rationale: The best answer is SNRIs. This is correct because the defining characteristic of this
class is dual reuptake inhibition—blocking both serotonin transporters (SERT) and norepinephrine
transporters (NET). While TCAs also affect multiple monoamines, they work through different
mechanisms and have additional receptor effects. SNRIs like venlafaxine and duloxetine are